Cancer Drug dramatically shrinks Prostate Tumors, study finds - July 23, 2008

There is a general sense in the prostate cancer community that this agent is extremely promising and is very likely to have an important role in the management of prostate cancer patients,' said Dr. Howard M. Sandler, a radiation oncologist at the University of Michigan who is a spokesman for the American Society of Clinical Oncology.'It's pretty safe to say that we are going to have a lot more to offer patients when this drug gets approved,' added Dr. Robert Reiter, a urologist at UCLA's Jonsson Comprehensive Cancer Center who was not involved in the research.

Radiation helps even when Prostate Cancer returns - June 17, 2008

Radiation therapy can help prolong the lives of men with aggressive prostate cancer whose tumors return after surgery, U.S. researchers said on Tuesday.

Radiation therapy given within two years of recurrence cut the risk of dying from prostate cancer by two-thirds, compared with those who got no additional treatment, they said.

New Prostate Cancer Vaccine give hope to Metastatic Prostate Cancer patients  - May 24, 2008

A new prostate cancer vaccine may give hope to men with metastatic prostate cancer by enabling their immune systems to fight the disease. Researchers from the University of Iowa presented data on the adenovirus/PSA (Ad/PSA) vaccine during the Annual Scientific Meeting of the American Urological Association in Orlando .

In recent years, the concept of vaccine immunotherapy for advanced prostate cancer has become increasingly high profile as research has expanded. Major advances in the field have contributed significantly to the discussion of this important cancer therapy as researchers explore new ways to prolong survival and improve the quality of life in patients with metastatic disease.

Prostate-screening exams may miss cancer in obese patients, study shows - November 27, 2007

Higher blood volumes probably cause lower concentrations of prostate-specific antigen, or PSA, in obese prostate cancer patients, reports a study, leading the authors to speculate screening with PSA tests might miss some cancers in obese men.

Study Supports Change to Prostate Cancer Biopsy - October 2, 2007

Adding an extra step to the standard test for prostate cancer might improve treatment for some men, a new study finds.

Glaxo's Avodart and Flomax Help Prostate, Study Says (Update1)  - September 4, 2007

GlaxoSmithKline Plc's Avodart combined with Boehringer Ingelheim GmbH's Flomax improved symptoms of enlarged prostate gland better than either drug alone, a study found.

HIS HEALTH - Diet and prostate cancer - August 15, 2007

One's diet is believed to play an important role in the causation of prostate cancer. Epidemiological studies, looking at different populations where the incidence of prostate cancer varies widely, suggest that differences in diet may partly account for these variations.

Soy isoflavones may halve prostate cancer risk - July 25, 2007

Increased intake of soy isoflavones may cut the risk of prostate cancer by 58 per cent, suggests a new study from Japan .

Can Changing Your Lifestyle Help Treat Prostate Cancer? - July 9, 2007

Up to 73% of men with prostate cancer take nonprescription supplements, and smaller numbers use diet, exercise, or both in the hope of improving their outcome. Most of these men also receive conventional therapy, but a few depend on lifestyle alone. The appeal of lifestyle therapy is obvious but does it work?